Cutaneous Wegener's granulomatosis: A variant or atypical localized form?

Australasian Journal of Dermatology

Volumn 44, Issue 2, 2003, Pages 129-135

  Kuchel, Johanna ^a   Lee, Stephen ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Antineutrophil cytoplasmic antibody; Cyclophosphamide; Prednisone; Sinus; Ulcer

Indexed keywords

CIPROFLOXACIN; CYCLOPHOSPHAMIDE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

AGED; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; EARLY DIAGNOSIS; FEMALE; GRANULOMATOUS INFLAMMATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTEGUMENT; REMISSION; SKIN NODULE; SKIN ULCER; WEGENER GRANULOMATOSIS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY, NEEDLE; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; EAR, EXTERNAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; PREDNISONE; RECURRENCE; RISK ASSESSMENT; SKIN ULCER; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 0038017154     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-0960.2003.00660.x     Document Type: Article

References (31)

1. Weedon D. Vasculopathic reaction pattern. In: Skin Pathology. Edinburgh: Churchill Livingstone, 1997; 185-231.
2. Cassan SM, Coles DT, Harrison EG Jr. The concept of limited forms of Wegener's granulomatosis. Am. J. Med. 1970; 49: 566-79.
3. Kihiczak D, Nychay SG, Schwartz RA, McDonald RJ, Churg J, Lambert WC. Protracted superficial Wegener's granulomatosis. J. Am. Acad. Dermatol. 1994; 30: 865-6.
4. Fienberg R. The protracted superficial phenomenon in pathergic (Wegener's) granulomatosis. Hum. Pathol. 1981; 12: 458-67.
5. Hu CH, O'Loughlin S, Winkelmann RK. Cutaneous manifestations of Wegener's granulomatosis. Arch. Dermatol. 1977; 115: 175-82.
6. Hisler BM, Saltzman L. Cutaneous involvement in Wegener's granulomatosis. Cutis 1991; 48: 460-1.
7. Chyu JY, Hagstrom WJ, Soltani K, Faibisoff B, Whitney DH. Wegener's granulomatosis in childhood: Cutaneous manifestations as the presenting signs. J. Am. Acad. Dermatol. 1984; 10: 541-6.
8. Hansen LS, Silverman S Jr, Pons VG, Hales M, Greenspan JS, Sagebiel RW, Tuffanelli DL. Limited Wegener's granulomatosis. Report of a case with oral, renal, and skin involvement. J. Oral. Path. Med. 1985; 60: 524-51.
9. Figarella I, Bazarbachi T, Marie B, Sheid P, Martinet Y, Schmutz JL. Cutaneous nodules recurring in the legs ten years before the diagnosis of Wegener's granulomatosis. Rev. Med. Interne 2000; 21: 693-7 (In French).
10. Foltz V, Koeger AC, de Sauverzac C, de Person JF, Borgeois P, Fautrel B. Relapse of Wegener's granulomatosis. Concerning a case after 20 years of remission. Joint Bone Spine 2001; 68: 262-6.
11. Mandell BF, Hoffman GS. Systemic necrotising arthritis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds). Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999; 2035-44.
12. Wolff K, Stingl G. Pyoderma gangrenosum. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds). Fitzpatrick's Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999; 1140-8.
13. Daoud MS, Gibson LE, DeRemee RA, Specks U, el-Azhary RA, Su WP. Cutaneous Wegener's granulomatosis: Clinical, histopathologic, and immunopathologic features of third patients. J. Am. Acad. Dermatol. 1994; 51: 605-12.
14. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener's granulomatosis. A literature review and meta-analysis. Ann. Intern. Med. 1995; 123: 925-32.
15. Frances CLTH, Piette J-C, Saada V, Boisnic S, Wechsler B, Bletry O, Godeau P. Wegener's's granulomatosis. Dermatological manifestations in 75 cases with clinicopathologic correlation. Arch. Dermatol. 1994; 130: 861-7.
16. Wolff SM, Fauci AS, Horn RG, Dale DC. Wegener's granulomatosis. Ann. Intern. Med. 1974; 81: 513-25.
17. Patten SF, Tomecki KJ. Wegener's granulomatosis: Cutaneous and oral mucosal disease. J. Am. Acad. Dermatol. 1995; 28: 710-18.
18. Handfield-Jones SE, Parker SC, Fenton DA, Newton JA, Greaves MW. Wegener's granulomatosis presenting as pyoderma gangrenosum. Clin. Exp. Dermatol. 1992; 17: 197-200.
19. Elsner B, Harper FB. Disseminated Wegener's granulomatosis with breast involvement. Report of a case. Arch. Pathol. Lab. Med. 1969; 87: 544-7.
20. Fauci AS, Wolff SM. Wegener's granulomatosis: Studies in eighteen patients and a review of the literature. Medicine (Baltimore) 1973; 52: 535-61.
21. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann. Intern. Med. 1983; 98: 76-85.
22. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425-9.
23. Fienberg R, Mark EJ, Goodman M. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Hum. Pathol. 1993; 24: 160-8.
24. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotizing glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology? BMJ 1982; 285: 606.
25. Gross WL, Csernok E, Helmchen U. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis. APMIS 1995; 103: 81-97.
26. Burrows NP, Lockwood CM. Antineutrophil cytoplasmic antibodies and their relevance to the dermatologist. Br. J. Dermatol. 1995; 132: 173-81.
27. Newell LM, Malkinson FD. Commentary: Pyoderma gangrenosum. Arch. Dermatol. 1982; 118: 743-73.
28. Hickman JG, Lazarus GS. Pyoderma gangrenosum: A reappraisal of associated systemic diseases. Br. J. Dermatol. 1980; 102: 255-7.
29. Meyrick Thomas RH, Rowland Payne CME, Black MM. Wegener's granulomatosis presenting as pyoderma gangrenosum. Clin. Exp. Dermatol. 1982; 7: 523-8.
30. Reed WB, Jensen AK, Konwaler BE. The cutaneous manifestations in Wegener's granulomatosis. Acta Derm. Venereol. (Stockh.) 1963; 43: 250-64.
31. De Remee RA, McDonald TJ, Weiland LH. Wegener's granulomatosis: Observations on treatment with antimicrobial agents. Mayo Clin. Proc. 1985; 24: 160-8.